CVS Health CVS reported first-quarter earnings that beat analyst expectations Wednesday but cut its full-year guidance as it digests the acquisition of primary-care provider Oak Street Health. The early close of the $10.6 billion deal for Oak Street, completed on Tuesday, “will be a short-term headwind” for 2023 earnings, CVS president and CEO Karen Lynch said on a conference call with analysts Wednesday. CVS cut its 2023 guidance for adjusted per-share earnings to a range of $8.50 to $8.70, down from $8.70 to $8.90. …
Article Attribution | Read More at Article Source